Scholars Central

ArticlePublished 30 Apr 2022

microRNAs: Circulation in Medicines

Authors: Ke Xiong

Clinical Investigation

Volume 12 · Issue 4 · Pages 83–85

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Circulating microRNAs (c-microRNAs, c-miRNAs) are promising sensitive biomarkers for a variety of illnesses (oncological and cardiovascular diseases, neurological disorders, and so on), and their profiles precisely represent the status of the body. Studies of microRNA markers' expression demonstrate that they can assist detect a wide range of disorders before clinical symptoms appear, as well as analyse a patient's response to therapy in order to rectify and tailor therapies. The newest advancements in the use of miRNAs for detecting and treating different illnesses, both viral and non-viral, are discussed in this review. Exogenous microRNAs can be employed as high-precision therapeutic agents for these goals, according to the findings.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Investigation.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Investigation
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Ke Xiong”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels